GB-Salisbury: Pharmaceutical In Vitro Protein binding and blood partitioning Study

The project is developing a medicinal product. As such it is planned to administer the two active pharmaceutical ingredients (APIs) of interest to humans in clinical trials. To maximise the understanding of how these APIs behave when administered to humans it is important to gain knowledge of their binding to plasma proteins and blood components. The results from these assays will be used to improve the understanding of the pharmacokinetics of these drugs as the project progresses. This requirement is for the in vi...